| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $120.3M | -9.3% |
| R&D Expense | $12.8M | -29.5% |
| SG&A Expense | $50.2M | -23.4% |
| Operating Income | -$31.9M | +67.3% |
| Interest Expense | $23.6M | -21.2% |
| Pre-tax Income | $10.1M | +108.7% |
| Income Tax | $536K | +140.4% |
| Net Income | $9.5M | +108.2% |
| EPS (Basic) | $0.07 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $28.8M | +75.2% |
| Short-term Investments | $5.8M | -18.8% |
| Accounts Receivable | $13.5M | -20.5% |
| Current Assets | $57.2M | +14.8% |
| Total Assets | $326.2M | -12.0% |
| Current Liabilities | $51.3M | -21.9% |
| Long-term Debt | $147.1M | -33.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.3M | +85.1% |
| Investing Cash Flow | $89.2M | +538.9% |
| Financing Cash Flow | -$71.4M | -691.5% |
| +108.0% |
| EPS (Diluted) | $0.07 | +108.0% |
| Total Liabilities |
| $228.4M |
| -30.2% |
| Stockholders' Equity | $97.8M | +125.1% |